Skip to main content

GOLDMAN SACHS GROUP INC

Position in CAPR — Capricor Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in CAPR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$27,724,070
+$14,795,282 QoQ
Shares Held
911,976
+103.6% QoQ
Ownership
1.57%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
20 quarters on record
Voting authority Sole 99.9912278393291.ToString("F0")% Shared 0.ToString("F0")% None 0.008772160670894848.ToString("F0")%

Common Shares in CAPR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,293,152,367 across 364 Biotechnology names. CAPR ranks #77 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CAPR

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $27,724,070 911,976
2025-12-31 $12,928,788 447,983
2025-09-30 $1,266,377 175,642
2025-06-30 $714,671 71,971
2025-03-31 $3,901,727 411,141
2024-12-31 $4,067,798 294,768
2024-09-30 $1,190,395 78,264
2024-06-30 $394,459 82,696
2024-03-31 $1,447,416 213,169
2023-12-31 $74,523 15,240
2023-09-30 $83,957 24,549
2023-06-30 $117,344 24,549
2023-03-31 $103,913 24,624
2022-12-31 $94,932 24,594
2022-09-30 $149,784 24,964
2022-06-30 $87,072 24,949
2022-03-31 $144,876 42,238
2021-12-31 $89,121 30,417
2021-09-30 $88,994 22,138
2020-06-30 $178,516 38,808